ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INVA Innoviva Inc

15.26
0.27 (1.80%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Innoviva Inc INVA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.27 1.80% 15.26 07:16:11
Open Price Low Price High Price Close Price Previous Close
15.01 14.98 15.285 15.26 14.99
more quote information »

Recent News

Date Time Source Heading
24/4/202421:00BWInnoviva Specialty Therapeutics’ Positive Phase 3 Oral..
08/3/202411:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202411:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202410:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202408:15EDGAR2Form 8-K - Current report
01/3/202408:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
23/2/202413:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202413:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202412:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/11/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202300:30EDGAR2Form 8-K - Current report
02/11/202307:30EDGAR2Form 8-K - Current report
02/11/202307:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
02/11/202307:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
19/9/202322:30BWInnoviva to Participate in the Cantor Global Healthcare..
18/9/202322:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
01/9/202310:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202303:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202307:24EDGAR2Form 8-K - Current report
26/8/202306:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
08/8/202306:42EDGAR2Form 8-K - Current report
03/8/202311:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202306:15EDGAR2Form 8-K - Current report
03/8/202306:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
11/7/202322:16EDGAR2Form 8-K - Current report
07/6/202306:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
24/5/202309:10DJNFDA Approves Innoviva's Bacterial Pneumonia Treatment
24/5/202308:42BWInnoviva Specialty Therapeutics Announces FDA Approval for..
12/5/202308:45BWResults from Pivotal Phase 3 ATTACK Trial of Investigational..
10/5/202306:32BWInnoviva Reports First Quarter 2023 Financial Results and..
29/4/202307:30BWInnoviva Announces Retirement of Board Chairman

Your Recent History

Delayed Upgrade Clock